Financial Sense Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-46,305
| Closed | -$1.18M | – | 173 |
|
|
2025
Q3 | $1.18M | Buy |
46,305
+12,628
| +37% | +$312K | 0.2% | 73 |
|
|
2025
Q2 | $816K | Buy |
33,677
+205
| +0.6% | +$4.78K | 0.19% | 73 |
|
|
2025
Q1 | $848K | Buy |
33,472
+11,081
| +49% | +$290K | 0.24% | 62 |
|
|
2024
Q4 | $594K | Sell |
22,391
-4,676
| -17% | -$127K | 0.2% | 73 |
|
|
2024
Q3 | $783K | Buy |
27,067
+4,186
| +18% | +$122K | 0.21% | 69 |
|
|
2024
Q2 | $640K | Buy |
22,881
+26
| +0.1% | +$716 | 0.2% | 79 |
|
|
2024
Q1 | $634K | Buy |
+22,855
| New | +$634K | 0.21% | 78 |
|
|
2023
Q1 | – | Sell |
-2,833
| Closed | -$122K | – | 101 |
|
|
2022
Q4 | $145K | Buy |
+2,833
| New | +$136K | 0.06% | 93 |
|
|
2022
Q2 | – | Sell |
-5,711
| Closed | -$296K | – | 131 |
|
|
2022
Q1 | $296K | Buy |
+5,711
| New | +$296K | 0.11% | 62 |
|
|
2021
Q2 | – | Sell |
-23,649
| Closed | -$857K | – | 127 |
|
|
2021
Q1 | $857K | Sell |
23,649
-5,614
| -19% | -$199K | 0.29% | 58 |
|
|
2020
Q4 | $1.08M | Sell |
29,263
-932
| -3% | -$34.2K | 0.39% | 48 |
|
|
2020
Q3 | $1.05M | Sell |
30,195
-815
| -3% | -$28.6K | 0.42% | 45 |
|
|
2020
Q2 | $962K | Sell |
31,010
-6,665
| -18% | -$226K | 0.34% | 45 |
|
|
2020
Q1 | $1.17M | Buy |
37,675
+7,672
| +26% | +$261K | 0.52% | 35 |
|
|
2019
Q4 | $1.11M | Buy |
30,003
+13,700
| +84% | +$488K | 0.41% | 43 |
|
|
2019
Q3 | $556K | Buy |
+16,303
| New | +$593K | 0.27% | 46 |
|
|
2018
Q4 | – | Sell |
-136,100
| Closed | -$5.69M | – | 63 |
|
|
2018
Q3 | $5.69M | Buy |
136,100
+35,076
| +35% | +$1.35M | 2.4% | 13 |
|
|
2018
Q2 | $3.48M | Sell |
101,024
-4,695
| -4% | -$160K | 2.42% | 11 |
|
|
2018
Q1 | $3.56M | Buy |
+105,719
| New | +$3.63M | 1.73% | 15 |
|
|
2017
Q2 | – | Sell |
-6,541
| Closed | -$212K | – | 92 |
|
|
2017
Q1 | $212K | Sell |
6,541
-1,367
| -17% | -$43.1K | 0.13% | 68 |
|
|
2016
Q4 | $244K | Buy |
+7,908
| New | +$241K | 0.16% | 68 |
|
|
2016
Q3 | – | Sell |
-8,042
| Closed | -$269K | – | 85 |
|
|
2016
Q2 | $269K | Buy |
8,042
+7
| +0.1% | +$223 | 0.15% | 62 |
|
|
2016
Q1 | $226K | Sell |
8,035
-181,017
| -96% | -$5.17M | 0.13% | 70 |
|
|
2015
Q4 | $5.79M | Sell |
189,052
-4,255
| -2% | -$134K | 2.71% | 7 |
|
|
2015
Q3 | $5.76M | Sell |
193,307
-18,492
| -9% | -$593K | 3.99% | 4 |
|
|
2015
Q2 | $6.74M | Buy |
211,799
+1,839
| +0.9% | +$59.9K | 3.14% | 5 |
|
|
2015
Q1 | $6.93M | Buy |
209,960
+44,168
| +27% | +$1.4M | 2.9% | 6 |
|
|
2014
Q4 | $4.9M | Buy |
165,792
+4,942
| +3% | +$142K | 1.98% | 19 |
|
|
2014
Q3 | $4.51M | Sell |
160,850
-2,585
| -2% | -$72.5K | 1.93% | 19 |
|
|
2014
Q2 | $4.6M | Buy |
163,435
+3,722
| +2% | +$106K | 1.8% | 18 |
|
|
2014
Q1 | $4.87M | Buy |
159,713
+554
| +0.3% | +$16.5K | 2.1% | 14 |
|
|
2013
Q4 | $4.63M | Sell |
159,159
-78,310
| -33% | -$2.28M | 1.95% | 17 |
|
|
2013
Q3 | $6.47M | Buy |
237,469
+3,314
| +1% | +$90.2K | 2.81% | 9 |
|
|
2013
Q2 | $6.22M | Buy |
+234,155
| New | +$6.47M | 2.78% | 11 |
|
Other funds holding PFE
Financial Sense Advisors's PFE Position: Q4 2025 in Review
Financial Sense Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 46,305 shares — an estimated $1.18M sold.
Financial Sense Advisors first reported a position in PFE in Q2 2013 and held it in 34 quarters. The position peaked at $6.93M in Q1 2015. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Financial Sense Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Financial Sense Advisors sold 46,305 Pfizer shares in Q4 2025, an estimated $1.18M.
- Financial Sense Advisors first reported a position in Pfizer in Q2 2013 and held it in 34 quarters.
- Financial Sense Advisors's Pfizer position peaked at $6.93M in Q1 2015.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Financial Sense Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.